Illumina Reagents and Consumables
SAM.GOV Due: June 18, 2025 at 04:00 PM UTC
In-Active Presolicitation NONE Source Url

Summary

The National Heart, Lung, and Blood Institute (NHLBI) is seeking to negotiate and award a contract modification for Illumina Reagents and Consumables without providing for full and open competition. This opportunity is specifically aimed at Illumina, Inc., which is the sole source for the required reagents and consumables necessary for the operation of various Illumina sequencing and genotyping systems used by the NIH. The work involves supplying essential reagents and consumables that are critical for the efficient operation of these systems, which are utilized for high-throughput DNA sequencing and genetic analysis. Contractors with capabilities in providing brand-name reagents and consumables compatible with Illumina systems should consider bidding on this opportunity, as it is tailored for a specific vendor due to the unique requirements of the NIH's research operations.
Description

THIS IS A NOTICE OF INTENT SYNOPSIS TO AWARD A CONTRACT MODIFICATION WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND- NAME).

The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA) on behalf of the National Human Genome Research Institu

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
334516
Set Aside
NONE : No Set aside used
Place of Performance
San Diego , California 92122
Point of Contact
Full Name Email Phone Type
MUELLER, ETHAN J [email protected] 13014962153 primary
Maxwell, Dorothy L. [email protected] 3018277729 secondary
Attachments
  • REV+Mod+SAM+NOI+pre-sol-notice_illumina_final_6-3-25.pdf
  • 75N92025R00033.pdf